Bionano Genomics, Inc. (BNGO) › Cash & EquivalentsBionano Genomics, Inc. (BNGO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2017: $1.02M2018: $16.52M2019: $17.31M2020: $38.45M2021: $24.57M2022: $5.09M2023: $17.95M2024: $9.17M2025: $2.99M$2.99M2017Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$2.99M-67.4%2024$9.17M-48.9%2023$17.95M+252.5%2022$5.09M-79.3%2021$24.57M-36.1%2020$38.45M+122.1%2019$17.31M+4.8%2018$16.52M+1516.9%2017$1.02M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share